验证数据展示
经过测试的应用
Positive WB detected in | Daudi cells, Raji cells, Ramos cells |
Positive IF/ICC detected in | Live U-937 cells |
推荐稀释比
应用 | 推荐稀释比 |
---|---|
Western Blot (WB) | WB : 1:500-1:3000 |
Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
产品信息
29567-1-AP targets PLCG2 in WB, IF/ICC, ELISA applications and shows reactivity with human samples.
经测试应用 | WB, IF/ICC, ELISA Application Description |
经测试反应性 | human |
免疫原 | Peptide 种属同源性预测 |
宿主/亚型 | Rabbit / IgG |
抗体类别 | Polyclonal |
产品类型 | Antibody |
全称 | phospholipase C, gamma 2 (phosphatidylinositol-specific) |
别名 | Phospholipase C-gamma-2, Phospholipase C IV, Phospholipase C gamma 2, Phosphoinositide phospholipase C-gamma-2, EC:3.1.4.11 |
计算分子量 | 148 kDa |
观测分子量 | 148 kDa |
GenBank蛋白编号 | BC007565 |
基因名称 | PLCG2 |
Gene ID (NCBI) | 5336 |
RRID | AB_2918326 |
偶联类型 | Unconjugated |
形式 | Liquid |
纯化方式 | Antigen affinity purification |
UNIPROT ID | P16885 |
储存缓冲液 | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
储存条件 | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
Phospholipase C-gamma2 (PLCG2) is a transmembrane signaling enzyme that catalyzes the conversion of 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate to 1D-myo-inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG) using calcium as a cofactor.IP3 and DAG are second messenger molecules important for transmitting signals from growth factor receptors and immune system receptors across the cell membrane. Mutations in this gene have been found in autoinflammation, antibody deficiency, and immune dysregulation syndrome and familial cold autoinflammatory syndrome 3.
实验方案
Product Specific Protocols | |
---|---|
WB protocol for PLCG2 antibody 29567-1-AP | Download protocol |
IF protocol for PLCG2 antibody 29567-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |